Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1661-1670 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|May 22, 2014
Antibodies to watch in 2014: mid-year updateJanice M Reichert
Mabs|January 16, 2014
Site-specific antibody drug conjugates for cancer therapySiler Panowski, Sunil Bhakta, Helga Raab, et al.
Mabs|January 16, 2014
IgE immunotherapy: a novel concept with promise for the treatment of cancerDebra H Josephs, James F Spicer, Panagiotis Karagiannis, et al.
Mabs|January 16, 2014
Antibody light chain variable domains and their biophysically improved versions for human immunotherapyDae Young Kim, Rebecca To, Hiba Kandalaft, et al.
Mabs|August 30, 2021
Sensitive, homogeneous, and label-free protein-probe assay for antibody aggregation and thermal stability studiesSalla Valtonen, Emmiliisa Vuorinen, Ville Eskonen, et al.
Mabs|August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapySarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Mabs|August 3, 2022
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD micePeng Zhao, Yuanzhong Xu, Xuejun Fan, et al.
Mabs|March 20, 2023
Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formatsAndreas V Madsen, Peter Kristensen, Alexander K Buell, et al.
Mabs|March 2, 2023
eIg-based bispecific T-cell engagers targeting EGFR: Format mattersLennart Kühl, Annelie K Schäfer, Sebastian Kraft, et al.
Mabs|May 5, 2021
Animal immunization merges with innovative technologies: A new paradigm shift in antibody discoveryPonraj Prabakaran, Sambasiva P Rao, Maria Wendt
Pageof 178

Showing results (1661-1670 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|May 22, 2014
Antibodies to watch in 2014: mid-year updateJanice M Reichert
Mabs|January 16, 2014
Site-specific antibody drug conjugates for cancer therapySiler Panowski, Sunil Bhakta, Helga Raab, et al.
Mabs|January 16, 2014
IgE immunotherapy: a novel concept with promise for the treatment of cancerDebra H Josephs, James F Spicer, Panagiotis Karagiannis, et al.
Mabs|January 16, 2014
Antibody light chain variable domains and their biophysically improved versions for human immunotherapyDae Young Kim, Rebecca To, Hiba Kandalaft, et al.
Mabs|August 30, 2021
Sensitive, homogeneous, and label-free protein-probe assay for antibody aggregation and thermal stability studiesSalla Valtonen, Emmiliisa Vuorinen, Ville Eskonen, et al.
Mabs|August 4, 2022
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapySarah C Cowles, Allison Sheen, Luciano Santollani, et al.
Mabs|August 3, 2022
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD micePeng Zhao, Yuanzhong Xu, Xuejun Fan, et al.
Mabs|March 20, 2023
Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formatsAndreas V Madsen, Peter Kristensen, Alexander K Buell, et al.
Mabs|March 2, 2023
eIg-based bispecific T-cell engagers targeting EGFR: Format mattersLennart Kühl, Annelie K Schäfer, Sebastian Kraft, et al.
Mabs|May 5, 2021
Animal immunization merges with innovative technologies: A new paradigm shift in antibody discoveryPonraj Prabakaran, Sambasiva P Rao, Maria Wendt
Pageof 178